Viking Therapeutics Inc (NASDAQ: VKTX) on Tuesday, plunged -3.13% from the previous trading day, before settling in for the closing price of $36.46. Within the past 52 weeks, VKTX’s price has moved between $18.92 and $43.55.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.00%. The company achieved an average annual earnings per share of -169.12%. With a float of $109.84 million, this company’s outstanding shares have now reached $112.45 million.
Viking Therapeutics Inc (VKTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Viking Therapeutics Inc is 2.83%, while institutional ownership is 65.27%. The most recent insider transaction that took place on Oct 28 ’25, was worth 216,492. In this transaction Chief Operating Officer of this company sold 6,185 shares at a rate of $35.00, taking the stock ownership to the 382,467 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Director sold 60,000 for $35.57, making the entire transaction worth $2,134,278. This insider now owns 30,000 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.32 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.27) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -169.12% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Viking Therapeutics Inc (VKTX) is currently performing well based on its current performance indicators. A quick ratio of 28.34 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -3.75 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
The latest stats from [Viking Therapeutics Inc, VKTX] show that its last 5-days average volume of 1.91 million was inferior to 4.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 61.68%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 61.22%, which indicates a significant increase from 31.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.49 in the past 14 days, which was lower than the 1.89 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.25, while its 200-day Moving Average is $30.40. Now, the first resistance to watch is $36.25. This is followed by the second major resistance level at $37.18. The third major resistance level sits at $37.70. If the price goes on to break the first support level at $34.80, it is likely to go to the next support level at $34.28. Assuming the price breaks the second support level, the third support level stands at $33.35.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
Market capitalization of the company is 3.99 billion based on 113,036K outstanding shares. Right now, sales total 0 K and income totals -109,960 K. The company made 0 K in profit during its latest quarter, and -90,790 K in sales during its previous quarter.
